PALISADE BIO, INC. Investing Cash Flow
PALISADE BIO, INC. (PALI) reported Investing Cash Flow of $0 for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-24.
Financial Statements › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivities · last filed 2025-03-24
- PALISADE BIO, INC. net cash provided by (used in) investing activities for the quarter ending 2024-12-31 was $0.00.
- PALISADE BIO, INC. net cash provided by (used in) investing activities for the quarter ending 2024-09-30 was $0.00.
- PALISADE BIO, INC. net cash provided by (used in) investing activities for the quarter ending 2023-12-31 was $0.00.
- PALISADE BIO, INC. net cash provided by (used in) investing activities for the quarter ending 2023-09-30 was $0.00.
- PALISADE BIO, INC. net cash provided by (used in) investing activities for fiscal 2024 was $0.00.
- PALISADE BIO, INC. net cash provided by (used in) investing activities for fiscal 2023 was -$4.00K.
- PALISADE BIO, INC. net cash provided by (used in) investing activities for fiscal 2022 was -$10.00K.
- PALISADE BIO, INC. net cash provided by (used in) investing activities for fiscal 2021 was -$54.00K.
| Period end | Net Cash Provided by (Used in) Investing Activities 3 month | Net Cash Provided by (Used in) Investing Activities 6 month | Net Cash Provided by (Used in) Investing Activities 9 month | Net Cash Provided by (Used in) Investing Activities 12 month |
|---|---|---|---|---|
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-24 | $0.00 derived: sum of 2 quarters · filed 2025-03-24 | $0.00 10-K · filed 2025-03-24 | |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $0.00 10-Q · filed 2024-11-12 | ||
| 2024-06-30 | $0.00 10-Q · filed 2024-08-12 | |||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-24 | $0.00 derived: sum of 2 quarters · filed 2025-03-24 | -$4.00K 10-K · filed 2025-03-24 | |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$4.00K 10-Q · filed 2024-11-12 | ||
| 2023-06-30 | -$4.00K 10-Q · filed 2024-08-12 | |||
| 2022-12-31 | -$10.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-26 | -$10.00K derived: sum of 2 quarters · filed 2024-03-26 | -$10.00K 10-K · filed 2024-03-26 | |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $0.00 10-Q · filed 2023-11-09 | ||
| 2022-06-30 | $0.00 10-Q · filed 2023-08-10 | |||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-22 | -$348.00K derived: sum of 2 quarters · filed 2023-03-22 | -$54.00K 10-K · filed 2023-03-22 | |
| 2021-09-30 | -$348.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -$54.00K 10-Q · filed 2022-11-14 | ||
| 2021-06-30 | $294.00K 10-Q · filed 2022-08-15 | |||
| 2020-12-31 | -$1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-17 | $0.00 derived: sum of 2 quarters · filed 2022-03-17 | -$6.00K 10-K · filed 2022-03-17 | |
| 2020-09-30 | $1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | -$5.00K 10-Q · filed 2021-11-12 | ||
| 2020-06-30 | -$6.00K 10-Q · filed 2021-08-23 | |||
| 2018-12-31 | -$1.71K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-27 | -$1.71K derived: sum of 2 quarters · filed 2020-03-27 | -$1.71K derived: sum of 3 quarters · filed 2020-03-27 | $5.00M 10-K · filed 2020-03-27 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | $0.00 derived: sum of 2 quarters · filed 2019-11-14 | $5.00M 10-Q · filed 2019-11-14 | $5.00M derived: sum of 4 quarters · filed 2019-11-14 |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | $5.00M 10-Q · filed 2019-08-14 | $5.00M derived: sum of 3 quarters · filed 2019-08-14 | $5.00M derived: sum of 4 quarters · filed 2019-08-14 |
| 2018-03-31 | $5.00M 10-Q · filed 2019-05-14 | $5.00M derived: sum of 2 quarters · filed 2019-05-14 | $5.00M derived: sum of 3 quarters · filed 2019-05-14 | |
| 2017-12-31 | -$408.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-22 | -$598.00 derived: sum of 2 quarters · filed 2019-03-22 | -$94.05K 10-K · filed 2019-03-22 | |
| 2017-09-30 | -$190.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14 | -$93.64K 10-Q · filed 2018-11-14 | ||
| 2017-06-30 | -$93.45K 10-Q · filed 2018-08-13 | |||
| 2016-12-31 | -$5.03M derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-02 | $2.36M 10-K · filed 2018-04-02 | ||
| 2016-09-30 | $7.39M 10-Q · filed 2017-11-08 | |||
| 2013-09-30 | -$207.11K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12 | -$347.90K derived: sum of 2 quarters · filed 2013-11-12 | -$444.72K 10-Q · filed 2013-11-12 | -$511.26K derived: sum of 4 quarters · filed 2013-11-12 |
| 2013-06-30 | -$140.79K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-08 | -$237.61K 10-Q · filed 2013-08-08 | -$304.15K derived: sum of 3 quarters · filed 2013-08-08 | -$342.77K derived: sum of 4 quarters · filed 2013-11-12 |
| 2013-03-31 | -$96.82K 10-Q · filed 2013-05-10 | -$163.36K derived: sum of 2 quarters · filed 2013-05-10 | -$201.98K derived: sum of 3 quarters · filed 2013-11-12 | -$322.91K derived: sum of 4 quarters · filed 2013-11-12 |
| 2012-12-31 | -$66.54K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-15 | -$105.17K derived: sum of 2 quarters · filed 2013-11-12 | -$226.09K derived: sum of 3 quarters · filed 2013-11-12 | -$254.86K 10-K · filed 2013-03-15 |
| 2012-09-30 | -$38.63K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12 | -$159.55K derived: sum of 2 quarters · filed 2013-11-12 | -$188.32K 10-Q · filed 2013-11-12 | -$249.11K derived: sum of 4 quarters · filed 2013-11-12 |
| 2012-06-30 | -$120.92K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-08 | -$149.69K 10-Q · filed 2013-08-08 | -$210.48K derived: sum of 3 quarters · filed 2013-08-08 | -$342.92K derived: sum of 4 quarters · filed 2013-08-08 |
| 2012-03-31 | -$28.77K 10-Q · filed 2013-05-10 | -$89.56K derived: sum of 2 quarters · filed 2013-05-10 | -$221.99K derived: sum of 3 quarters · filed 2013-05-10 | -$414.93K derived: sum of 4 quarters · filed 2013-05-10 |
| 2011-12-31 | -$60.79K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-15 | -$193.22K derived: sum of 2 quarters · filed 2013-03-15 | -$386.16K derived: sum of 3 quarters · filed 2013-03-15 | -$480.85K 10-K · filed 2013-03-15 |
| 2011-09-30 | -$132.44K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-09 | -$325.37K derived: sum of 2 quarters · filed 2012-11-09 | -$420.06K 10-Q · filed 2012-11-09 | -$545.85K derived: sum of 4 quarters · filed 2012-11-09 |
| 2011-06-30 | -$192.94K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-09 | -$287.63K 10-Q · filed 2012-08-09 | -$413.42K derived: sum of 3 quarters · filed 2012-08-09 | -$501.42K derived: sum of 4 quarters · filed 2012-08-09 |
| 2011-03-31 | -$94.69K 10-Q · filed 2012-05-09 | -$220.48K derived: sum of 2 quarters · filed 2012-05-09 | -$308.48K derived: sum of 3 quarters · filed 2012-05-09 | |
| 2010-12-31 | -$125.79K derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-30 | -$213.79K derived: sum of 2 quarters · filed 2012-03-30 | -$332.68K 10-K · filed 2012-03-30 | |
| 2010-09-30 | -$88.00K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2011-11-09 | -$206.88K 10-Q · filed 2011-11-09 | ||
| 2010-06-30 | -$118.88K 10-Q/A · filed 2011-09-23 | |||
| 2009-12-31 | -$210.78K 10-K · filed 2012-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lexeo Therapeutics, Inc. (LXEO) | United States | $0.278B | -4.19 |
| FATE THERAPEUTICS INC (FATE) | United States | $0.280B | -2.51 |
| Invivyd, Inc. (IVVD) | United States | $0.270B | -2.42 |
| Liminatus Pharma, Inc. (LIMN) | United States | $0.282B | |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| Inhibikase Therapeutics, Inc. (IKT) | United States | $0.296B | -4.44 |
| X4 Pharmaceuticals, Inc (XFOR) | United States | $0.297B | -4.99 |
| SAB Biotherapeutics, Inc. (SABS) | United States | $0.306B | -25.49 |
| Century Therapeutics, Inc. (IPSC) | United States | $0.306B | -4.02 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |